It was another big week for the Nasdaq Composite. The IPO “window” isn’t entirely closed, but the pickings have been slim. There were 21 new offerings in January and February combined, but just a dozen deals since, seven of them health-care companies. Read More...
It was another big week for the Nasdaq Composite. The IPO “window” isn’t entirely closed, but the pickings have been slim. There were 21 new offerings in January and February combined, but just a dozen deals since, seven of them health-care companies.
Add Comment